We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Robotics Aid Diagnostic and Surgical Bronchoscopic Procedures

By HospiMedica International staff writers
Posted on 06 Nov 2019
A new study confirms that a robot-assisted bronchoscopy platform can successfully localize undiagnosed lung lesions.

Researchers at the Medical University of South Carolina (MUSC; Charleston, USA) conducted a study to examine the safety and feasibility of the Auris Health (Redwood City, CA, USA) Monarch Platform, which visualizes peripheral lung nodules in the bronchial tree using a combination of direct visualization, navigational guidance, and radial endobronchial ultrasound (R-EBUS). More...
The study, which involved 55 patients across five study sites, showed successful localization of the targeted pulmonary lesions in 96.3% of the procedures. Pneumothorax occurred in two patients and required tube thoracostomy in one. No other serious adverse events were reported.

"We were able to safely perform the procedure and successfully localize lesions in 96% of cases. This data suggests robot-assisted bronchoscopy is feasible and may improve bronchoscopists' ability to effectively localize peripheral lesions,” said study co-author Professor Gerard Silvestri, MD, a lung cancer pulmonologist at MUSC, when the study was presented at the annual CHEST conference, held in New Orleans (LA, USA) in October 2019. “The promising results of this study warrant further evaluation in additional prospective studies where yield can be better assessed.”

The Monarch Platform consists of four major components - the patient side system (PSS), a controller cart, a master device workstation, and the bronchoscope and accessories. The master/slave system uses a controller-like interface to navigate the flexible robotic endoscope to the periphery of the lung. The PSS operates two robot arms with six degrees of freedom, and an instrument drive mechanism (IDM) with four actuated axes. The robotic arms steer the flexible bronchoscope, attached at the end effector of the robotic arm, which also includes a working channel and a camera; the working channel of the bronchoscope is used for irrigation and aspiration.

More patients die every year from lung cancer than from prostate, breast, and colon cancers combined. More than 90% of people diagnosed with lung cancer do not survive, in part because it is often found at an advanced stage. There are a variety of diagnostic options currently available for lung cancer, but all have limitations in accuracy, safety, or invasiveness, which can lead to false positives, false negatives, or side effects such as pneumothorax (collapsed lung) and hemorrhage.

Related Links:
Medical University of South Carolina
Auris Health


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.